Gts Securities LLC Roivant Sciences Ltd. Transaction History
Gts Securities LLC
- $45.4 Billion
- Q3 2024
A detailed history of Gts Securities LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Gts Securities LLC holds 10,000 shares of ROIV stock, worth $111,500. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,000Holding current value
$111,500% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding ROIV
# of Institutions
315Shares Held
507MCall Options Held
1.26MPut Options Held
2.52M-
Sb Investment Advisers (Uk) LTD London, X065.9MShares$735 Million6.27% of portfolio
-
Qvt Financial LP New York, NY65.8MShares$734 Million73.2% of portfolio
-
Viking Global Investors LP54.1MShares$603 Million2.42% of portfolio
-
Vanguard Group Inc Valley Forge, PA41.7MShares$465 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$394 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.85B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...